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Exonuclease-1 (EXO1) mediates checkpoint
induction in response to telomere dysfunction
in yeast, but it is unknown whether EXO1 has
similar functions in mammalian cells. Here we
show that deletion of the nuclease domain of
Exo1 reduces accumulation of DNA damage
and DNA damage signal induction in telomere-
dysfunctional mice. Exo1 deletion improved
organ maintenance and lifespan of telomere-
dysfunctionalmice but did not increase chromo-
somal instability or cancer formation. Deletion
of Exo1 also ameliorated the induction of DNA
damage checkpoints in response to g-irradia-
tion and conferred cellular resistance to 6-thio-
guanine-induced DNA damage. Exo1 deletion
impaired upstream induction of DNA damage
responses by reducing ssDNA formation and
the recruitment of Replication Protein A (RPA)
and ATR at DNA breaks. Together, these stud-
ies provide evidence that EXO1 contributes to
DNA damage signal induction in mammalian
cells, and deletion of Exo1 can prolong survival
in the context of telomere dysfunction.
INTRODUCTION
Telomeres form the ends of eukaryotic chromosomes
(Blackburn, 2001). The main function of telomeres is to
cap chromosomal ends, thus preventing induction ofCDNA damage pathways. Telomere capping function
depends on telomere length and telomere structure (de
Lange, 2005). Due to the end replication problem of DNA
polymerase and the processing of telomeres during cell
cycle progression, telomeres shorten with each round of
cell division (Shay and Wright, 2000).
Telomere shortening limits the proliferative lifespan of
primary human cells (Allsopp et al., 1992) and can reduce
regenerative reserve and organ homeostasis during aging
and chronic diseases (for review see Djojosubroto et al.,
2003). In mammalian cells telomere shortening leads to
telomere dysfunction inducing senescence or apoptosis
(Lechel et al., 2005; Lee et al., 1998; Wright and Shay,
1992). Critically short telomeres lose chromosome-
capping function. The most upstream response to telomere
uncapping is the formation of DNA damage foci at dys-
functional telomeres (d’Adda di Fagagna et al., 2003;
Takai et al., 2003). These DNA damage foci activate down-
stream DNA damage signals, which involve the ATM and
ATR kinases (d’Adda di Fagagna et al., 2003) inducing
the p53 pathway (Chin et al., 1999; Vaziri and Benchimol,
1996). Cell cycle arrest and apoptosis in response to telo-
mere dysfunction represent a tumor suppressor mecha-
nism (Wright and Shay, 1992). As a downside, these
checkpoints may contribute to decreased regenerative
reserve and impaired organ maintenance in response to
telomere dysfunction and aging (Choudhury et al., 2007).
The generation of telomerase-deficient mice, which
carry a homozygous deletion of the telomerase RNA com-
ponent (mTerc/), has delivered a unique tool to study
consequences of telomere dysfunction in vivo. Late gen-
eration (G3) mTerc/ mice exhibit cellular and molecular
phenotypes induced by telomere dysfunction, includingell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc. 863
activation of the p53-DNA-damage pathway, impaired
proliferation, increased apoptosis, and chromosomal fu-
sions (Lee et al., 1998; Rudolph et al., 1999; Chin et al.
1999). Mice with dysfunctional telomeres show impaired
maintenance of organs with high rates of cell turnover
and premature aging of these compartments (Lee et al.,
1998; Rudolph et al., 1999; Choudhury et al. 2007; Hao
et al. 2005; Hemann et al. 2001).
Telomere-dysfunctional mice have been used to ana-
lyze the function of different components of the DNA dam-
age pathway in the context of telomere dysfunction in vivo
(Qi et al., 2003; Wong et al., 2003; Chin et al., 1999; Artandi
et al., 2000; Greenberg et al., 1999; Choudhury et al.,
2007). These studies have shown that activation of the
p53 pathway has a major role in mediating the adverse
effects of telomere dysfunction on organismal aging, but
at the same time, this pathway has a pivotal role in pre-
venting the evolution of chromosomal instability and can-
cer initiation in response to telomere dysfunction (Chin
et al., 1999; Artandi et al., 2000). Of note, ATM deletion
did not rescue premature aging of telomere-dysfunctional
mice (Wong et al. 2003), indicating that ATM-independent
pathways can activate p53 in response to telomere dys-
function possibly involving ATR (d’Adda di Fagagna
et al., 2003) —a gene involved in activation of DNA dam-
age signals in response to generation of single-stranded
DNA (ssDNA) (Zou et al., 2003). The induction of chromo-
somal instability and tumor initiation in response to
telomere dysfunction is linked to the evolution of chromo-
somal instability and the formation of nonreciprocal
translocation (Artandi et al., 2000). This response appears
to be initiated by DNA repair pathways that induce chro-
mosomal fusions in response to telomere uncapping,
with the consequence of fusion-bridge-breakage cycles
(Maser et al., 2007a; Smogorzewska et al., 2002).
Exonuclease-1 (EXO1) is a 50-30 exonuclease. A role of
EXO1 for the induction of checkpoints in response to telo-
mere dysfunction has been revealed in studies on yeast.
Deletion of Exo1 rescued the induction of senescence in
telomere-dysfunctional yeast strains (Maringele and Ly-
dall, 2002). In addition, EXO1 processing of dysfunctional
telomeres has been implicated in generating chromo-
somal translocation in response to telomere dysfunction
in yeast (Hackett and Greider, 2003). EXO1 can also medi-
ate survival of telomere-dysfunctional yeast strains by
increasing homologous recombination at dysfunctional
telomeres (Maringele and Lydall, 2004). Knockout mice
carrying a deletion mutation of the nuclease domain of
Exo1 are viable, but show defects in DNA mismatch
repair, accompanied by slightly increased cancer suscep-
tibility at advanced age (Wei et al., 2003).
The role of EXO1 in response to telomere dysfunction
and DNA breaks in mammalian cells is unknown. Here
we show that Exo1 deletion rescues the accumulation of
DNA damage in telomere-dysfunctional mice, as well as
DNA damage signal induction in response to g-irradiation
(g-IR) and at laser-induced DNA breaks. In vivo, Exo1
deletion improved organ maintenance and prolonged life-864 Cell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc.span of telomere-dysfunctional mice without accelerating
chromosomal instability or cancer formation.
RESULTS
Exo1 Deletion Prolongs the Lifespan of Mice with
Dysfunctional Telomeres without Accelerating
Tumor Formation
Mice carrying a deletion of the nuclease domain of Exo1
(DExon 6 =Exo1+/, Wei et al., 2003) were crossed for three
generations with mTerc/ mice on a C57BL/6J back-
ground. As previously reported the lifespan of G3 mTerc/
mice (n = 25) was shortened compared with mTerc+/+,
Exo1+/+ mice (n = 89, p < 0.0001, Figure 1A). Homozygous
Exo1 deletion (Exo1/) shortened the lifespan ofmTerc+/+
mice (p = 0.009, Figure 1A; Wei et al., 2003). An increase in
spontaneous cancer has been reported in Exo1/ mice of
a mixed genetic background (Wei et al. 2003). In agree-
ment with the relative cancer resistance of the C57BL/6J
mouse strain, the overall cancer incidence was low in our
mouse cohorts (Figure 1B and Table S1 in the Supple-
mental Data, available with this article online), and Exo1
deletion did not result in a significant increase in cancer
formation, indicating that other factors may contribute to
the lifespan reduction in mTerc+/+, Exo1/ mice.
In contrast to the effects on lifespan of mTerc+/+ mice,
deletion of Exo1 significantly prolonged survival of G3
mTerc/, Exo1/ mice (n = 34) compared with G3
mTerc/, Exo1+/+ mice (p < 0.0001, Figure 1A). This res-
cue in lifespan was associated with an improvement of
overall fitness, as reflected by an increase in body weight
of aging G3 mTerc/, Exo1/ mice compared with G3
mTerc/, Exo1+/+ mice (p = 0.0002, Figure S1A in the
Supplemental Data available with this article online). Nota-
bly, Exo1 deletion did not accelerate tumor formation in
G3 mTerc/ mice (Figure 1B, p = 0.3).
Exo1 Deletion Rescues Organ Maintenance
in Aging Telomere-Dysfunctional Mice
G3 mTerc/ mice are phenotypically normal at the age of
3 months, but show an atrophy of the intestinal epithelium
and impaired hematolymphopoiesis at the age of 12–15
months (Rudolph et al., 1999; Choudhury et al. 2007).
The evolution of these phenotypic changes correlates
with the progression of telomere dysfunction in aging G3
mTerc/ mice. A survey of our aging cohorts showed
that Exo1 deletion rescued organ maintenance in 12- to
15-month-old G3 mTerc/ mice (Figures 1C–1F and Fig-
ures 2A–2F). In a cohort of 24-month-old G3 mTerc/,
Exo1/ mice (n = 4), not in 24-month-old mTerc+/+ mice
(Figures 1D and 1F and Figures 2B and 2C), some of the
phenotypes of impaired organ maintenance appeared,
indicating that Exo1 deletion transiently rescued organ
maintenance in G3 mTerc/ mice, but that EXO1-inde-
pendent mechanisms limited organ maintenance in very
old G3 mTerc/, Exo1/ mice.
Deletion of Exo1 did not rescue testis atrophy in G3
mTerc/ mice because Exo1 deletion itself causes
Figure 1. Exo1 Deletion Prolongs the Lifespan of Telomere-Dysfunctional Mice without Accelerating Cancer Formation
(A) Survival curves for mTerc+/+, Exo1+/+ (n = 89), mTerc+/+, Exo1/ (n = 27), G3, Exo1+/+ (n = 25), and G3, Exo1/ mice (n = 34).
(B) Tumor-free survival curves for the indicated mouse cohorts.
(C) Representative photographs of whole-mount staining of the colon of 12- to 15-month-old mice of the indicated genotypes (magnification bar,
500 mm).
(D) Histogram of the number of crypts per low-power vision field (353) in the colon of 12- to 15- and 24-month-old mice of the indicated genotypes
(n = 4–6 mice per group; data are shown as mean; error bars represent standard deviation [SD]).
(E) Representative photographs of H&E-stained longitudinal sections of the small intestine of 12- to 15-month-old mice of the indicated genotypes
(magnification bar, 200 mm).
(F) Histogram of the number of basal crypts per vision field (1003) in the small intestine of 12- to 15- and 24-month-old mice of the indicated geno-
types (n = 4–5 mice per group; data are shown as mean; error bars represent SD).Cell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc. 865
Figure 2. Exo1 Deletion Rescues Lymophopoiesis in Aging Telomere-Dysfunctional Mice
(A) Representative photographs of H&E-stained longitudinal sections of the spleen of 12- to 15-month-old mice of the indicated genotypes (magni-
fication bar, 500 mm). The lymphocytes containing white pulp are circled.
(B) Histogram of the frequency of B lymphocytes in spleen of 12- to 15- and 24-month-old mice of the indicated genotypes (n = 4–6 mice per group;
data are shown as mean; error bars represent SD).
(C) Histogram showing the total number of B lymphocytes (B220+) and T lymphocytes (CD8+ or CD4+) in total bone marrow (collected from two hind
legs) of 12- to 15- and 24-month-old mice of the indicated genotypes (n = 4–8 mice per group; data are shown as mean; error bars represent SD).
(D) Representative FACS plots showing B lymphocytes (B220+) in bone marrow of 12- to 15-month-old mice of the indicated genotypes.
(E) Histogram showing the total number of thymocytes of 12- to 15-month-old mice of the indicated genotypes (n = 5 mice per group; data are shown
as mean; error bars represent SD).
(F) Representative FACS plots showing T cell development in thymus of 12- to 15-month-old mice of the indicated genotypes. Note that the percent-
age of CD8+, CD4+ (double positive) T cells (immature T cells) is reduced in G3, Exo1+/+ but rescued in G3, Exo1/ mice.866 Cell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc.
Figure 3. Exo1 Deletion Rescues Cell Proliferation and Reduces Apoptosis in Telomere-Dysfunctional Mice
(A) Representative photographs of BrdU-stained crypts in the small intestine of 12- to 15-month-old mice of the indicated genotypes (magnification
bars, 200 mm).
(B) Histogram showing the percentage of BrdU- and PCNA-negative crypts in the small intestine of 12- to 15- and 24-month-old mice of the indicated
genotypes (n = 4–5 mice per group; data are shown as mean; error bars represent SD).
(C) Representative photographs of apoptotic cells (green nuclei) in basal crypts (circled) of the small intestine of 12- to 15-month-old mice of the in-
dicated genotypes (magnification bars, 200 mm).
(D) Histogram showing the number of TUNEL-positive nuclei per basal crypts in the small intestine of 12- to 15- and 24-month-old mice of the indi-
cated genotypes (n = 4–5 mice per group; data are shown as mean; error bars represent SD).meiotic defects resulting in testis atrophy and sterility in
both male and female mTerc+/+ mice (Wei et al., 2003).
Exo1 Deletion Reduces Cell Cycle Arrest and
Apoptosis in Intestinal Crypts of Aging G3
mTerc/ Mice
Impaired maintenance of high-turnover organs in telo-
mere-dysfunctional mice has been linked to increased ap-
optosis and impaired cell proliferation (Lee et al., 1998). In
agreement with previous studies (Choudhury et al., 2007),
the rate of BrdU incorporation was reduced in basal intes-
tinal crypts of aged G3 mTerc/ mice compared with that
of mTerc+/+ mice (Figures 3A and 3B). Exo1 deletion
partially rescued proliferation rates of intestinal basal
crypts in G3 mTerc/, Exo1/ mice compared with G3
mTerc/, Exo1+/+ mice (n = 5 mice per group, p = 0.0041,
Figures 3A and 3B). Elevated rates of apoptosis were
present in basal crypts of 12- to 15-month-old G3
mTerc/ mice compared with age-matched mTerc+/+
mice (Figures 3C and 3D). Deletion of Exo1 reduced apo-
ptosis in 12- to 15-month-old G3 mTerc/, Exo1/ mice
compared with G3mTerc/, Exo1+/+ mice (n = 5 mice per
group, p = 0.001). An increase in apoptosis and cell cyclearrest appeared in intestinal crypts of 24-month-old G3
mTerc/, Exo1/ mice (Figures 3B and 3D).
Exo1 Deletion Does Not Rescue Telomere
Dysfunction in Aging G3mTerc/ Mice
Studies in yeast have shown that defects in mismatch
repair genes can promote telomerase-independent prolif-
eration (Rizki and Lundblad, 2001). In mammalian cells,
telomerase-independent immortalization of cells involves
the activation of an alternative lengthening mechanism
of telomeres (ALT), which is based on homologous recom-
bination and characterized by an overall lengthening of
telomeres and an increase in telomere length heterogeneity
(Bryan et al., 1995; Chang et al., 2003). An analysis of telo-
mere length in basal intestinal crypts (Figure 4A), splenic
white pulp (data not shown), and bone marrow
(Figure S1B) of 12- to 15-month-old mice revealed a re-
duction of the average telomere length and an increase
in the frequency of cells with critically short telomeres in
G3 mTerc/ mice compared with mTerc+/+ mice. This re-
duction in telomere length in G3 mTerc/ mice was not
rescued by Exo1 deletion (Figure 4A and Figure S1B).
We also did not see an increase of telomere lengthCell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc. 867
Figure 4. Exo1 Deletion Does Not Res-
cue Telomere Function but Does Impair
Formation of Chromosomal Fusions in
mTerc/ Mice
(A) The histograms show the distribution of
telomere fluorescence intensities (TFI) over all
analyzed nuclei of mTerc+/+, Exo1+/+ (n = 276
nuclei), mTerc+/+, Exo1/ (n = 160 nuclei),
G3, Exo1+/+ (n = 242 nuclei) and G3, Exo1/
(n = 263 nuclei) mice. The red dotted lines indi-
cate the mean value of each genotype. The
black line marks the threshold of critically short
telomeres (TFI < 200 arbitrary units).
(B) Histogram of the rate of telomere-free ends
per metaphase in bone marrow cells of 12- to
15-month-old mice of the indicated genotypes
(n = 4–5 mice per group; data are shown as
mean; error bars represent SD).
(C) Representative photograph of a metaphase
of a G3, Exo1/ mouse, with white arrow
pointing to telomere-free ends (magnification
bar, 4 mm).
(D) Histogram of the rate of anaphase bridges
per total number of anaphases in basal crypts
of small intestine of 12- to 15-month-old mice
of the indicated genotypes (n = 5 mice per
group; data are shown as mean; error bars
represent SD).
(E) Representative photograph showing an
anaphase bridge in basal crypts of small intes-
tine (magnification bar, 20 mm).
(F) Representative photograph of SKY analysis
showing no translocations in a metaphase
spread from bone marrow of 24-month-old
G3 mTerc/, Exo1/ mice.heterogeneity in G3 mTerc/, Exo1/. Together, there is
no evidence of systemic activation of ALT that rescued
survival and organ maintenance in G3 mTerc/, Exo1/
mice. As a direct marker of telomere dysfunction, telo-
mere-free chromosome ends were present in bone mar-
row-derived metaphases of G3 mTerc/ mice but rarely
in mTerc+/+ mice (Figures 4B and 4C). Exo1 deletion did
not rescue the prevalence of telomere-free ends in G3
mTerc/ mice (Figures 4B and 4C). Instead there was
a further increase in telomere-free ends in G3 mTerc/,
Exo1/ mice, likely due to the abrogation of checkpoint
responses (Figure 3).
Exo1 Deletion Reduces Chromosomal Fusion and
Does Not Increase Chromosomal Translocations
in Telomerase Knockout Mice
Telomere dysfunction induces chromosomal fusion by
activation of DNA repair pathways (Maser et al., 2007b;868 Cell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc.Smogorzewska et al., 2002). We analyzed the rate of
anaphase bridges—a morphological correlate of chro-
mosomal fusions (Kirk et al., 1997; Rudolph et al.,
2001)—in the intestine of aging mice. There was a signif-
icant increase in anaphase bridges in G3 mTerc/,
Exo1+/+ mice compared with those in age-matched
wild-type mice, but Exo1 deletion rescued the formation
of anaphase bridges in G3 mTerc/ mice (Figures 4D
and 4E). Spectral karyotyping (SKY) analysis on meta-
phase spreads from bone marrow cells did not reveal
recurrent chromosomal translocations in 12- to 15-
month-old G3 mTerc/, Exo1+/+ mice (data not shown).
Notably, deletion of Exo1 did not result in any detectable
increase in chromosomal translocations in bone marrow
cells from 24-month-old G3 mTerc/, Exo1/ mice
(Figure 4F, n = 4 mice). Together, these results indicated
that Exo1 deletion reduced the formation of chromo-
somal fusions and did not increase chromosomal
instability in G3 mTerc/, Exo1/ mice with an extended
lifespan.
We did not detect a significant effect of Exo1 deletion on
telomeric g-strand integrity in mouse embryonic fibro-
blasts (Figures S2A–S2D).
Exo1 Deletion Prevents DNA Damage
Accumulation and Reduces DNA Damage
Signaling in Telomere-Dysfunctional Mice
The formation of DNA damage foci represents the most
upstream molecular event associated with DNA damage
signal induction in response to telomere dysfunction
(d’Adda di Fagagna et al., 2003; Satyanarayana et al.,
2004). DNA damage foci containing gH2AX and 53BP1
were detected in basal intestinal crypts of 12- to 15-
month-old G3 mTerc/ mice (Figures 5A–5D), but not in
age-matched mTerc+/+ mice (Figures S3A and S3B).
Exo1 deletion reduced the accumulation of DNA damage
foci in G3 mTerc/, Exo1/ mice (Figures 5A–5D). Co-
staining of gH2AX with TUNEL-positive, apoptotic cells
revealed that DNA damage foci were present in nonapop-
totic cells of aging G3 mTerc/ mice, indicating that the
DNA damage foci staining did not reflect DNA breaks in
apoptotic cells (Figure S3C). Only 14% of the total number
of DNA damage foci (gH2AX or 53BP1) colocalized with
telomeres (Figures S3D and S3E). These data indicated
that Exo1 deletion impaired the accumulation of DNA
damage, likely including extratelomeric DNA damage, in
telomere-dysfunctional mice.
Activation of DNA damage signaling in response to dys-
functional telomeres and DNA damage involves p53 and
its downstream target, p21 (Chin et al., 1999; Brown
et al., 1997; Choudhury et al., 2007). In 12- to 15-month-
old G3 mTerc/, Exo1+/+ mice, nuclear expression of
p53 was detected in 47%, and p21, in 9.5%, of basal in-
testinal crypts (Figures 5E–5H). p53 and p21 expression
was not detected in mTerc+/+ mice (Figures 5F and 5H,
Figures S4A and S4B). Both p53 and p21 upregulation
was reduced in G3 mTerc/, Exo/ mice compared
with that of G3 mTerc/, Exo+/+ mice (p < 0.001).
Exo1 Deletion Impairs Checkpoint Induction
and DNA Damage Signaling in Response to g-IR
To analyze whether the effects of EXO1 were specific for
telomeric DNA damage or reflected a more general role
of EXO1 in response to DNA damage, we analyzed the
role of EXO1 in response to different types of DNA dam-
age. Exo1 deletion significantly rescued cell cycle arrest
(Figures 6A and 6B, p = 0.01) and apoptosis (Figures 6A
and 6C, p = 0.03) in basal intestinal crypts of g-irradiated
mice (24 hr after 4Gy). Similarly, cultures of Exo1/ ear
fibroblasts exhibited reduced checkpoint responses com-
pared with Exo1+/+ ear fibroblasts in response to g-IR
(Figures 6D and 6E and Figure S4C). Exo1 deletion also
increased the resistance of cells treated with 6-thiogua-
nine—a purine analog inducing DNA damage (Figure 6F);
however, Exo1 gene status had no significant effect on
the sensitivity of cultured cells in response to hydroxyurea treatment (Figure S4D). Exo1 deletion did not affect
the formation of gH2AX foci in g-irradiated fibroblasts
(data not shown) or in the intestine of g-irradiated mice
(Figure 6G). However, intestinal epithelial cells of irradi-
ated Exo1/ mice, compared with those of irradiated
Exo+/+ mice, showed a significant reduction in 53BP1
foci formation (Figure 6H) and reduced induction of p53
and p21 (Figures S4E and S4F). Exo1 deletion also re-
duced phosphorylation of CHK2 and p53 in g-irradiated fi-
broblasts (Figure 6I and Figures S4G and S4H). Of note,
total protein levels of CHK2 and p53 did not differ between
nonirradiated Exo1/ versus Exo1+/+ fibroblasts, indicat-
ing that Exo1 gene status by itself had no effect on total
protein levels (Figure 6I and Figures S4G and S4H). Total
protein levels of p53 were increased in g-irradiated
Exo1+/+ fibroblasts (Figure 6I and Figures S4G and S4H),
in agreement with the observation that phosphorylation
of p53 stabilizes the protein in response to g-IR (Chen
et al. 1994)—a response that was diminished in g-irradi-
ated Exo1/ fibroblasts. A similar mechanism could ex-
plain the slight increase in total protein levels of CHK2 in
response to g-IR in Exo1+/+ fibroblasts and the impaired
increase of total CHK2 levels in Exo1/ fibroblasts.
Exo1 Deletion Impairs Upstream DNA Damage
Signal Induction
Together, our results indicated that Exo1 deletion did not
prevent gH2AX foci formation but did impair the induction
of DNA damage signals at DNA breaks. Studies in yeast
have shown that EXO1 generates ssDNA at dysfunctional
telomeres, and the generation of ssDNA has been shown
to induce DNA damage signals in yeast and mammalian
cells (Garvik et al., 1995; Lee et al., 1998; Lydall and Wei-
nert, 1995; Zou et al., 2003). To analyze whether EXO1 can
generate ssDNA at DNA breaks in mammalian cells, we
used the experimental system of laser-induced DNA
breaks (Maser et al., 1997; Rogakou et al., 1999; Green-
berg et al., 2006). Nondenaturing BrdU staining revealed
a significant reduction in ssDNA formation in Exo1/ ver-
sus Exo1+/+ fibroblasts at laser-induced DNA breaks
(Figures 7A and 7B). gH2AX staining at laser-induced
DNA breaks was not affected by Exo1 gene status, but
recruitment of Replication Protein A (RPA) to laser-
induced breaks was reduced in Exo1/ versus Exo1+/+
fibroblasts (Figures 7C and 7D). Cell cycle profiles were
similar in nonirradiated Exo1/ and Exo1+/+ fibroblasts,
indicating that inherent differences in cell proliferation
did not influence these results (Figures S5A and S5B). The
generation of ssDNA and RPA binding at ssDNA leads to
an activation of ATR (Namiki and Zou, 2006). Western blot
analysis showed an impaired induction of phospho-ATR in
g-irradiated Exo1/ versus Exo1+/+ fibroblasts
(Figure 7E and Figure S5C). In addition, the formation of
ATR foci was impaired in nuclei of g-irradiated Exo1/
versus Exo1+/+ ear fibroblasts (Figures 7F and 7G). Immu-
nostaining did not reveal ATR foci in aging mTerc+/+ mice
(Figure S5D). Notably, 12- to 15-month-old G3 mTerc/,
Exo1+/+ mice showed nuclear foci of ATR in intestinalCell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc. 869
Figure 5. Exo1DeletionPreventsAccumulationofDNADamageandReducesDNADamageSignaling inTelomere-DysfunctionalMice
(A) Representative photographs showing g-H2AX-positive cells (white arrows) in basal crypts of 12- to 15-month-old mice of the indicated genotypes
(magnification bars, 20 mm). The inlet shows a nucleus containing g-H2AX foci at high-power magnification.
(B) Histogram showing the percentage of g-H2AX-positive basal crypts in 12- to 15- and 24-month-old mice of the indicated genotypes (n = 4–5 mice per
group; data are shown as mean; error bars represent SD).
(C) Representative photographs showing 53BP1 foci (white arrows) in basal crypts of 12- to 15-month-old mice of the indicated genotypes (magnification
bars, 20 mm). The inlet shows a nucleus containing 53BP1 foci at high-power magnification.
(D) Histogram showing the number of 53BP1 foci per basal crypt in 12- to 15- and 24-month-old mice of the indicated genotypes (n = 4–5 mice per group;
data are shown as mean; error bars represent SD).
(E) Representative photographs showing p53-positive cells (white arrows) in basal crypts of 12- to 15-month-old mice of the indicated genotypes (mag-
nification bars, 50 mm).
(F) Histogram showing the percentage of p53-positive basal crypts in 12- to 15- and 24-month-old mice of the indicated genotypes (n = 4–5 mice per
group; data are shown as mean; error bars represent SD).
(G) Representative photographs showing p21-positive nuclei (red arrows) in basal crypts of 12- to 15-month-old mice of the indicated genotypes (mag-
nification bars, 100 mm).
(H) Histogram showing the percentage of p21-positive intestinal basal crypts of 12- to 15- and 24-month-old mice of the indicated genotypes (n = 4–5
mice per group; data are shown as mean; error bars represent SD).870 Cell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc.
basal crypts, but ATR foci formation was reduced in 12- to
15-month-old G3 mTerc/, Exo1/ mice (n = 4 mice per
group, p = 0.001, Figures 7H and 7I). ATR foci appeared in
nuclei of intestinal basal crypts of 24-month-old G3
mTerc/, Exo1/ mice (Figure 7I), indicating that
EXO1-independent mechanisms can activate ATR in
very old double knockout mice.
DISCUSSION
This study provides direct experimental evidence that
EXO1 induces DNA damage responses in mammalian
cells. Moreover, Exo1 deletion prevents the accumulation
of DNA damage and prolongs lifespan of telomere-
dysfunctional mice.
Exo1 Deletion Impairs the Induction of DNA
Damage Signals
The current study shows that Exo1 deletion impairs the
induction of checkpoint responses and confers resistance
of mammalian cells and organs to g-IR, telomere dysfunc-
tion, and 6-thioguanine treatment. The study points to the
formation of ssDNA as one mechanism by which EXO1
amplifies the generation of DNA damage signals at DNA
breaks. Previous studies on yeast have shown that the
generation of ssDNA is required for DNA damage signal
induction (Garvik et al., 1995; Lee et al., 1998; Lydall and
Weinert, 1995; Zou et al., 2003). Similar mechanisms exist
in mammalian cells (Zou et al., 2003). However, the mole-
cular mechanisms leading to the formation of ssDNA in
response to DNA damage are not completely understood.
In yeast, EXO1 has been shown to induce ssDNA in
response to telomere dysfunction (Maringele and Lydall,
2002). Our study provides, to our knowledge, the first
evidence that the nuclease domain of EXO1 participates
in the formation of ssDNA, RPA recruitment, and ATR
activation at DNA double-strand breaks and in response
to telomere dysfunction in mammalian cells. This mecha-
nism likely contributes to aggravate phenotypes of
telomere dysfunction inmTerc/ mice. Notably, Exo1 de-
letion did not rescue cell survival in response to Hydroxy
urea (HU) treatment. A possible explanation is that HU
induces ssDNA-dependent signaling independent of
EXO1 processing, since HU induces single-stranded
DNA damage by itself.
Exo1 Deletion Impairs the Accumulation of DNA
Damage in Telomere-Dysfunctional Mice
Although EXO1 does not prevent gH2AX foci formation in
response to g-IR and laser treatment, Exo1 deletion mark-
edly reduced the accumulation of gH2AX foci in vivo in
mTerc/ mice. These data indicate that dysfunctional
telomeres induce EXO1-dependent processes that lead
to an accumulation of further DNA damage. Cells having
undergone replicative senescence due to telomere short-
ening display numerous gH2AX foci throughout the ge-
nome that do not colocalize with telomeric regions (Sedel-
nikova et al., 2004). It is possible that Exo1 deletionCreduces the secondary formation of DNA damage in re-
sponse to telomere dysfunction by inhibiting chromo-
somal fusions and fusion-bridge-breakage cycles that
create extratelomeric DNA damage in telomere-dys-
functional mice. In agreement with this hypothesis, Exo1
deletion reduces the number of anaphase bridges in telo-
mere-dysfunctional mice (Figures 4D and 4E). Other, less
obvious mechanisms might be involved. It has been
shown that telomere dysfunction increases intracellular
ROS levels in senescent cells (Passos et al., 2007). Al-
though the exact mechanisms are not understood, it is
possible that deletion of Exo1 also reduces the accumula-
tion of ROS and thereby the accumulation of DNA damage
in senescent cells. Therefore, it is conceivable that EXO1
has different, additive effects on DNA damage accumula-
tion and DNA damage signal induction in telomere-
dysfunctional mice. Its role in DNA break processing could
directly contribute to the induction of DNA damage sig-
nals. In addition, EXO1 could increase the generation of
extratelomeric DNA damage in the context of chronic telo-
mere dysfunction. An accumulation of extratelomeric DNA
damage has been associated with organismal aging (Se-
delnikova et al., 2004). Based on our study, it is intriguing
to speculate that EXO1-dependent processes contribute
to this phenomenon.
Exo1 Deletion Rescues Organ Maintenance
and Lifespan of Telomere-Dysfunctional Mice
This study reveals that Exo1 deletion improves the main-
tenance of high-turnover organs and prolongs survival
of telomere-dysfunctional mice. These findings indicate
that EXO1-dependent mechanisms could represent
therapeutic targets to improve regeneration and organ ho-
meostasis in the context of telomere dysfunction. There is
growing evidence that telomere dysfunction can impair or-
gan function during human aging (Armanios et al., 2007;
Cawthon et al., 2003; Tsakiri et al., 2007; Vulliamy et al.,
2004) and chronic diseases (Ball et al., 1998; Wiemann
et al., 2002). Since organ homeostasis is maintained by
a balance of cell proliferation and apoptosis, it is likely
that the inhibition of cell cycle arrest and apoptosis im-
proved organ maintenance and lifespan of G3 mTerc/,
Exo1/ mice compared with G3 mTerc/, Exo1+/+
mice. This interpretation of the data stands in agreement
with our recent study that showed that deletion of p21 im-
proves cell proliferation and organ maintenance in telo-
mere-dysfunctional mice (Choudhury et al., 2007). The
current study also shows that cell cycle arrest and apopto-
sis were not completely rescued in G3 mTerc/, Exo1/
mice; checkpoint activation and phenotypes of impaired
organ homeostasis appeared in very old double knockout
mice, but not in mTerc+/+ mice. These data suggest that
mammalian cells possess EXO1-dependent and EXO1-
independent mechanisms for checkpoint induction in
response to telomere dysfunction. Consistent with this
notion, studies in yeast provide evidence that other exo-
nucleases participate in the processing of dysfunctional
telomeres (Tomita et al., 2003).ell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc. 871
Figure 6. Exo1 Deletion Impairs DNA Damage Signal Induction in Response to g-IR
(A) Representative photographs of BrdU-positive cells or TUNEL-positive cells in the intestinal basal crypts of 4-month-old mice of the indicated
genotypes, 24 hr after g-irradiation (g-IR). Magnification bars, 200 mm.
(B and C) Histogram showing the number of (B) BrdU-positive cells or (C) TUNEL-positive cells per crypt in the small intestine of 4-month-old
g-irradiated mice of the indicated genotypes (n = 5 mice per group; data are shown as mean; error bars represent SD).
(D and E) Cell cycle analysis in response to g-IR (24 hr after 15Gy). (D) Histogram showing the relative reduction of BrdU-positive cells in g-irradiated
compared with nonirradiated ear fibroblasts of the indicated genotypes (n = 3 cell lines per group; data are shown as mean; error bars represent SD).
(E) Histogram showing the relative increase in cells in G1 stage of the cell cycle in g-irradiated compared with nonirradiated ear fibroblasts of the
indicated genotypes (n = 3 cell lines per group; data are shown as mean; error bars represent SD).
(F) Survival curves of mouse embryonic stem cells of the indicated genotypes at 3–4 days after 6-thioguanine treatment at indicated doses.
Survival curves for Exo1–/– (complete gene knockout) and Exo1exon6D/ (knockout of the nuclease domain, which was used throughout this study)
were generated in two separate experiments. The survival curves for Msh2/ and WT are the averaged survival curves from two separate
experiments.
(G) Histogram showing the number gH2AX foci per nuclei in the small intestine of 4-month-old mice (n = 5 per group; data are shown as mean; error
bars represent SD) of the indicated genotypes, 24 hr after 4Gy g-IR.872 Cell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc.
Exo1 Deletion Does Not Increase the Rate
of Cancer Formation in Aging Telomere-
Dysfunctional Mice
The current study shows that Exo1 deletion did not in-
crease cancer formation in telomere-dysfunctional mice.
Studies in telomerase-deficient mice have shown that
telomere dysfunction can increase tumor initiation by in-
creasing chromosomal fusions and the rate of chromo-
somal instability (Artandi et al., 2000). Our study shows
that Exo1 deletion impaired anaphase bridge formation
in telomere-dysfunctional mice. These data are in agree-
ment with the model that the generation of chromosomal
fusions and consequent induction of fusion-bridge-break-
age cycles represent a major mechanism inducing chro-
mosomal instability and cancer initiation in the context of
telomere dysfunction (Maser and DePinho, 2002; Zhu
et al., 2003; O’Hagan et al., 2002; Maser et al., 2007a).
The current study suggests that EXO1 contributes to the
formation of chromosomal fusions and to the evolution
of chromosomal instability as a consequence of fusion-
bridge-breakage cycles. In agreement with this interpreta-
tion, it has been shown that EXO1 mediates translocations
at chromosome ends in response to telomere dysfunction
in yeast (Hackett and Greider, 2003).
In conclusion, our studies show that EXO1 is a critical
component for inducing DNA damage signals, cell cycle
arrest, and apoptosis in telomere-dysfunctional mice
and in response to DNA double-strand breaks. Moreover,
Exo1 deletion prevents the accumulation of DNA damage
and can prolong organismal survival in the context of
telomere dysfunction without accelerating chromosomal
instability and cancer formation.
EXPERIMENTAL PROCEDURES
Mouse Crosses and Survival
Exo1+/ mice were crossed with mTerc+/ mice to generate double
heterozygous mice, which in turn were crossed through successive
generations to produce G3 mTerc/, Exo1+/+ (n = 25) and G3,
Exo1/ mice (n = 34). Intercrosses between mTerc+/+, Exo1+/ gener-
ated mTerc+/+, Exo1+/+ (n = 89) and mTerc+/+, Exo1/ mice (n = 27).
Mice were on a C57BL/6J background.
In Vivo BrdU Incorporation Assay
In vivo proliferation was determined after 4 hr of BrdU labeling (i.p.
injection of 30 mg/kg body weight). Immunostaining was performed
on 5 mm thick paraffin sections using Cell Proliferation Kit (Amersham
Biosciences) according to the manufacturer’s instructions. The num-
ber of BrdU-positive and BrdU-negative crypts was counted in 20
low-power fields (2003) and the percentage of BrdU-negative crypts
was calculated.
FACS Analysis
For fluorescence-activated cell sorting analysis (FACS), thymus,
spleen, and hind limb bones were dissected and single-cell sus-Cpensions were stained with antibody cocktails (BD Pharmingen) for
15 min on ice.
TUNEL Staining
The rate of apoptosis was determined by TUNEL assay (In situ cell
death detection kit, Roche, Mannheim, Germany) on 5 mm thick paraf-
fin sections of small intestine. The number of apoptotic cells per crypt
was counted in 20 low-power fields (2003) per mouse (n = 4–5 mice
per group).
Staining for gH2AX, ATR, 53BP1, p53, and PCNA
Immunofluorescence was performed on 4 mm thick paraffin sections of
small intestine. Sections were deparaffinized and rehydrated and
permeabilized in 1 mM sodium citrate buffer. Primary antibodies
were used either over night at 4C or for 2 hr at room temperature:
gH2AX (UpState, 1:750 dilution), ATR (Cell Signaling, 1:100), 53BP1
(Cell Signaling, 1:100), p53 (R&D, 1:50) and PCNA (Calbiochem, 1:50
dilution). The following secondary antibodies were used: gH2AX
and PCNA: anti-mouse Cy3-Zymed (1:200 and 1:300 respectively);
53BP1: anti-rabbit Fitc-Zymed (1:150); p53: anti-goat Fitc-BD
Pharmingen (1:100).
p21 Staining
For p21 staining 5 mm thick paraffin sections of small intestine were
blocked with M.O.M. blocking reagent (Vector Labs) for 1 hr and
then incubated with mouse anti-mouse p21 (Santa Cruz) overnight at
4C. The subsequent steps to detect p21 signal was performed using
M.O.M. Immunodetection Kit (Vector Laboratories, USA).
ATR Staining on Mouse Ear Fibroblasts
Mouse ear fibroblasts were grown on coverslips and cells were fixed in
4% formaldehyde, permeabilized with 0.2% triton, washed twice with
PBS, and then treated with ATR antibody (1:500 dilution, Cell Signal-
ing) for 2 hr. The secondary antibody (anti-rabbit Fitc-conjugated, Dia-
nova) was used for 1 hr at room temperature. ATR-foci-positive cells
were counted in 40 low-power fields (4003).
Quantitative Fluorescence In Situ Hybridization, or qFISH
qFISH was performed as described (Satyanarayana et al., 2003) on
5 mm thick paraffin sections of small intestine and methanol/acetic-
acid-fixed bone marrow cells, respectively. Telomere length was ana-
lyzed from the nuclei of the basal crypts and bone marrow using the
TFL-Telo Software from Peter Lansdorp.
SKY
SKY was performed as described previously (Frank et al., 2004) and
according to the manufacturer’s instructions (Applied Spectral Imag-
ing, Ltd. [ASI]; Migdal HaEmek, Israel). Spectral images were acquired
using an epifluorescence microscope equipped with an interferometer
(SpectraCube ASI), a custom-designed optical filter, and the
SkyView software (ASI).
Western Blot
Whole-cell extracts of mouse ear fibroblasts were obtained in RIPA
lysis buffer. Protein was subjected to 10% SDS-PAGE and detected
using antibody against phosphor-ATR (1:1000, Cell Signaling), Phos-
pho-CHK2-T68 (1:1000, Abcam), phospho-p53-Ser15 (1:1000; Cell
Signaling), b-Actin (1:1000, Santa Cruz), pan-specific anti-p53 (R&D),
and pan-specific anti-CHK2 (Calbiochem).(H) Histogram showing the number of 53BP1 foci per crypt in the small intestine of 4-month-old mice (n = 5 per group; data are shown as mean; error
bars represent SD) of the indicated genotypes: 24 hr after 4Gy g-IR.
(I) Representative western blots showing expression of phosphorylated CHK2 (T68), phosphorylated p53 (Ser15), total CHK2 (pan specific Ab), total
p53 (pan specific AB), and b-actin as a loading control in g-irradiated and nonirradiated mouse ear fibroblasts of the indicated genotypes. Similar
results were obtained in triplicate experiments using pools of three cell lines per experiment.ell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc. 873
Figure 7. Exo1Deletion Impairs Formation of ssDNA, RPA Recruitment, and ATR Activation in Response to Telomere Dysfunction
and DNA Breaks
(A) Representative photographs and (B) histogram showing the formation of ssDNA (stained by nondenaturing BrdU staining) at laser-induced DNA
breaks (stained by a phospho-BRCA1-antibody) in fibroblasts of the indicated genotypes (n = 3 cell lines per group; data are shown as mean; error
bars represent SD). (C) Representative photographs and (D) histogram showing recruitment of RPA to laser-induced DNA breaks in fibroblasts of the
indicated genotypes. Note that gH2AX staining is independent of the Exo1 genotype, but recruitment of RPA is reduced in Exo1/ compared with
Exo1+/+ fibroblasts. (E) Western blot showing phosphorylated ATR (Ser345) in protein lysates from 15Gy g-irradiated ear fibroblasts at 24 hr after IR.
(F) Representative photograph of ATR foci formation in nuclei of g-irradiated (30 min after 2Gy) and nonirradiated ear fibroblasts of the indicated ge-
notypes. (G) Histogram showing the percentage of ATR-foci-positive nuclei of g-irradiated (30 min after 2Gy) and nonirradiated ear fibroblasts of the
indicated genotypes (n = 3 cell lines per group; data are shown as mean; error bars represent SD). (H) Representative photographs showing ATR foci
in nuclei of cells in basal crypts of 12- to 15-month-old mice of the indicated genotypes (magnification bar, 20 mm). (I) Histogram showing the per-
centage of ATR-positive basal crypts in 12- to 15- and 24-month-old mice of the indicated genotypes (n = 4–5 mice per group; data are shown as
mean; error bars represent SD).874 Cell 130, 863–877, September 7, 2007 ª2007 Elsevier Inc.
Cytotoxicity Assays
Cytotoxicity of 6-thioguanine and HU were determined by growth inhi-
bition assays (Horton et al., 2000). Cells were exposed to 6-thiogua-
nine and HU for 24 hr. After drug exposure, the plates were washed
and cells were grown in drug-free DMEM growth media for 3–4
days. Cells were counted in triplicates using a lysis procedure for the
6-thioguanine experiments (Butler, 1984). For HU-treated cells, after
48 hr of treatment, cells were trypsinized and counted under a micro-
scope and in a haemocytometer. Results are expressed in percent sur-
vival by comparing the number of surviving cells in drug-treated wells
to the number of control cells in untreated wells.
Proliferation Assay of Cell Cultures
Mouse ear fibroblasts were seeded in 10 cm dishes and grown over-
night. Cells were then irradiated with 15Gy irradiation, and 24 hr later
cells were trypsinized and fixed in 70% cold ethanol for analysis.
BrdU (10 mM) was added 3 hr before harvesting the cells. BrdU stain-
ing was performed according to the manufacturer’s instructions using
anti-Brdu (BD Pharmingen).
Laser-Generated DNA Double-Strand Breaks
Laser-generated DNA double-strand breaks were generated using
a P.A.L.M. MicroBeam laser (337 nm) microdissection system (Carl
Zeiss MicroImaging, Inc.) as previously described (Greenberg et al.,
2006; Lukas et al., 2003). Cells were grown on coverslips for 36–48
hr in media containing 10 mM BrdU (Sigma-Aldrich) prior to laser
treatment. Laser stripes were performed on 70–100 cells per coverslip.
Cells were returned to a cell culture incubator at 37C for 15 min.
Immunofluorescence Following Laser Stripes
Immunofluorescence following laser stripes was performed as previ-
ously described (Greenberg et al., 2006). In brief, paraformaldehyde-
fixed cells were permeabilized in PBS/0.5% triton for 5 min on ice.
Incubations with primary and secondary antibodies were carried out
at 37C for 20 min. Microscopy was performed on a Nikon Eclipse
80i integrated with ImageProTM 6.2 imaging software (Phase 3 Imag-
ing Systems) which was used to generate deconvolved images.
Statistics
Statistical analysis was done using Microsoft Excel and Graph Pad
Prism software. Unpaired Student’s t test was used to generate the
p values for the data sets. Survival curves were calculated using the
method of Kaplan and Meier.
Supplemental Data
The Supplemental Data for this article includes additional materials
and methods, five figures, and one table, and can be found online at
http://www.cell.com/cgi/content/full/130/5/863/DC1/.
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